Chicago, Illinois
Dr. Akanksha Srivastava, BDS, MSc, MDSc, FACP, FRCD(C), FAAMP, is a maxillofacial prosthodontist at the University of Illinois Health Craniofacial Center in Chicago. She is dual board-certified by the American Board of Prosthodontics and the Royal College of Dentists of Canada. She is a Diplomate of the American College of Prosthodontics and a Fellow of the American Association of Maxillofacial Prosthetics. Dr. Srivastava earned her BDS degree with a dean’s gold medal of honor from Dr. D.Y. Patil University, Navi Mumbai, India. She then went on to pursue a Master of Science degree at McGill University, Montreal, Canada where she focused her research program on health economics data for implant treatment. She completed her prosthodontics residency, certificate in implant surgery and master’s in dental science training from University of Connecticut. She further pursued a fellowship in Oral Oncology and Maxillofacial Prosthodontics from University of Texas MD Anderson Cancer Center.
Dr. Srivastava has over 60 published books, book chapters, abstracts, and manuscripts. She has won numerous awards for her academic achievements and is actively involved in various committees within the American College of Prosthodontics, American Academy of Maxillofacial Prosthetics, and American Association of Fixed Prosthodontics.
Dr. Srivastava works with the multidisciplinary team at the University of Illinois Health Craniofacial Center to provide care to children and adults with reconstructive needs, including cleft lip and palate, head and neck cancer, craniofacial trauma and other congenital and acquired orofacial conditions. She specializes in craniofacial implants and prosthetic rehabilitation, utilizing state-of-the art digital technologies to enhance her patient’s oral rehabilitation outcomes. Her research program encompasses oral morbidities associated with oncologic treatment which she conducts in close collaboration with the Department of Head and Neck Surgery at UT MD Anderson Cancer Center.
Friday, September 13, 2024
10:00 AM – 10:45 AM EDT
Disclosure information not submitted.